ROBERT C SLEDD
CIK 1207896 · Interim President & CEO · last filed 2026-08-06
ROBERT C SLEDD is an Interim President & CEO who has filed 112 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for UVV, was dated Aug 6, 2026. Across all open-market trades the lifetime net is −$32.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.52M
4
112
-$32.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UVV | Director | 14,647 | $46.13 | $675.7K | -$1.22M | 27 | 2026-08-06 |
| POOL | Director | 4,829 | $182.76 | $882.5K | -$23.34M | 46 | 2023-05-05 |
| ACCENDRA HEALTH INC/VA/ (OMI) Delisted | Director | 121,990 | $2.80 | $341.7K | $861.7K | 19 | 2021-03-02 |
| PFGC | Director | 110,500 | $99.20 | $10.96M | -$8.95M | 16 | 2008-05-28 |
Recent Filings
112 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-06 | UVV | Grant (A) | +2,650 | $0 | EDGAR |
| 2026-08-06 | UVV | Grant (A) | +2,650 | $0 | EDGAR |
| 2026-06-08 | UVV | Sell (S) | −2,845 | -$154.0K | EDGAR |
| 2026-06-03 | UVV | Notice (144) | −2,845 | -$153.0K | EDGAR |
| 2026-03-02 | UVV | Sell (S) | −1,000 | -$53.9K | EDGAR |
| 2026-02-26 | UVV | Notice (144) | −1,000 | -$53.5K | EDGAR |
| 2025-08-18 | UVV | Sell (S) | −4,617 | -$245.9K | EDGAR |
| 2025-08-15 | UVV | Notice (144) | −4,617 | -$244.2K | EDGAR |
| 2025-08-07 | UVV | Grant (A) | +2,290 | $0 | EDGAR |
| 2024-08-08 | UVV | Grant (A) | +2,660 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.